JPRN-UMIN000021291
Completed
未知
The effectiveness of oral hypoglycemic agents in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus. -Multiple comparison, Dapagliflozin, Pioglitazone vs Glimepiride- - The effectiveness of oral hypoglycemic agents in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus. -Multiple comparison, Dapagliflozin, Pioglitazone vs Glimepiride
Kawasaki Medical SchoolKawasaki Medical School Devision of Diabetes, Endocrinology and Metabolism0 sites90 target enrollmentMarch 2, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- onalcoholic fatty liver disease patients with type 2 diabetes
- Sponsor
- Kawasaki Medical SchoolKawasaki Medical School Devision of Diabetes, Endocrinology and Metabolism
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •A) Under 20 years old B) Treatment with insulin C) Treatment with SGLT\-2 inhibitor, thiazolidinedione or sulfonylurea D) Diabetic coma E) Renal dysfunction (eGFR\<45mL/min) F) Cardiac failure G) Viral hepatitis, alcoholic hepatitis, autoimmune hepatitis, liver cirrhosis H) Infection I) During treatment or treatment plan of malignant neoplasm J) Autoimmune disease K) Use of Steroid medicine and/or immunosuppressor L) Pregnant, possibility of pregnancy, nursing or hope to become pregnant during the study period M) In addition, when principal investigator or researcher deems inappropriate as a study subject
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study of effect of oral anti-diabetic medication on cognitive function in young and middle-aged type 2 diabetes mellitus patientsHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2020/02/023645Dr Vangaveti Sneha
Completed
Not Applicable
Comparative efficacy of oral hypoglycemic agents to be added to biphasic insulin aspart-70 (BIAsp70) in Japanese type 2 diabetic patients by using continuous glucose monitoring system (CGMS)T2DMJPRN-UMIN000010311St. Marianna University School of Medicine36
Recruiting
Not Applicable
Efficacy and safety of hypoglycemic agents in nonalcoholic fatty liver disease with type 2 diabetesJPRN-UMIN000045572ippon Medical School100
Completed
Not Applicable
Study of the oral hypoglycemic agent treatment after insulin therapy secessioJPRN-UMIN000009637Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine40
Completed
Not Applicable
Effect of oral hypoglycemic agent for postprandial hyperglycemia administered two times daily on glycemic control in patients with type 2 diabetes with Mitiglinide / Voglibose combination tabletsType 2 diabetesJPRN-UMIN000026185St.Marianna University School of Medicine50